A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
As an early event in the viral life cycle, the entry of enveloped viruses into target cells has received considerable attention. Viral fusion to cellular targets has been studied principally with fusion assays in which cells engineered to express the viral envelope are cultured with the target cells. These assays yield valuable information but do not fully recapitulate all of the variables governing the fusion of actual virions to their cellular targets. The virion membrane and the plasma membrane, for example, differ strikingly in their lipid and protein compositions. Two virion-based fusion assays have been described. One is based on the redistribution of a self-quenching fluorophore, whereas the second depends on photosensitized activation of a hydrophobic probe by a fluorescent lipid loaded into the target membrane. These assays are complex and have not been adapted to study fusion in complex cell populations. We have developed a simple, rapid assay allowing the detection of HIV-1 virion fusion to biologically relevant target cells, including primary CD4(+) T lymphocytes. It is based on the incorporation of beta-lactamase-Vpr chimeric proteins (BlaM-Vpr) into HIV-1 virions and their subsequent delivery into the cytoplasm of target cells as a result of virion fusion. This transfer is then detected by enzymatic cleavage of the CCF2 dye, a fluorescent substrate of beta-lactamase (BlaM), loaded in the target cells. BlaM cleaves the beta-lactam ring in CCF2, changing its fluor…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Nguyen, D. H., & Hildreth, J. E. K. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3264-3272.2000 · Cited by 788
A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
Baba, M., Nishimura, O., Kanzaki, N., Okamoto, M., Sawada, H., Iizawa, Y., Shiraishi, M., Aramaki, Y., Okonogi, K., Ogawa, Y., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5698 · Cited by 751 · cited 1×
“Conversely, no shift to increased blue fluorescence was observed in these CCR5-Jurkat T cells when the culture was preincubated with 250 nM TAK-779, an inhibitor of CCR5-dependent entr”
BackgroundZlokarnik, G., Negulescu, P. A., Knapp, T. E., Mere, L., Burres, N., Feng, L., Whitney, M., Roemer, K., & Tsien, R. Y. (1998) · Science · doi:10.1126/science.279.5347.84 · Cited by 690
Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4
Schols, D., Struyf, S., Damme, J. V., Esté, J. A., Henson, G., & Clercq, E. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1383 · Cited by 554 · cited 1×
“Consistent with this color change deriving from the fusion of virions to the target cells, essentially no blue cells were detected in virally infected HeLa-CD4 cells pretreated with 250 nM AMD3100, an inhibitor of CXCR4-dependent viral entr”
BackgroundAloia, R. C., Tian, H., & Jensen, F. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5181 · Cited by 440
Nussbaum, O., Broder, C. C., & Berger, E. A. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5411-5422.1994 · Cited by 338
Dynamic Disruptions in Nuclear Envelope Architecture and Integrity Induced by HIV-1 Vpr
de Noronha, C. M. C., Sherman, M. P., Lin, H. W., Cavrois, M. V., Moir, R. D., Goldman, R. D., & Greene, W. C. (2001) · Science · doi:10.1126/science.1063957 · Cited by 276 · cited 1×
“1-BlaM into the Hin dIII site of pCMV4-HA-Vpr (ref”
MethodSelf-citationHIV-1 Actively Replicates in Naive CD4+ T Cells Residing within Human Lymphoid Tissues
Eckstein, D. A., Penn, M. L., Korin, Y. D., Scripture-Adams, D. D., Zack, J. A., Kreisberg, J. F., Roederer, M., Sherman, M. P., Chin, P. S., & Goldsmith, M. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00217-5 · Cited by 232
Bridger, G. J., Skerlj, R. T., Thornton, D., Padmanabhan, S., Martellucci, S. A., Henson, G. W., Abrams, M. J., Yamamoto, N., & Vreese, K. D. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00002a019 · Cited by 209
Cytosolic Gag p24 as an Index of Productive Entry of Human Immunodeficiency Virus Type 1
Maréchal, V., Clavel, F., Heard, J. M., & Schwartz, O. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2208-2212.1998 · Cited by 207 · cited 1×
“However, in the absence of appropriate viral receptors in the vesicles, this entry pathway does not lead to productive infectio”
Background
Cited by
Items 401–490 of 490
Tissue‐like environments shape functional interactions of HIV‐1 with immature dendritic cells
Gallucci, L., Abele, T., Fronza, R., Stolp, B., Laketa, V., Ahmed, S. S., Flemming, A., Müller, B., Göpfrich, K., & Fackler, O. (2023) · EMBO Reports · doi:10.15252/embr.202356818 · Cited by 4
“…HIV-1 particles with iDC target cells, as assessed by the ability of virion-incorporated Vpr-Blam to convert the cytoplasmic blactamase substrate CCF2 following fusion (Cavrois et al, 2002) at 4 h.p.i., revealed that fusion was rendered more efficient by the 3D collagen environment (Fig 3D and E).”
MethodRodriguez-Plata, M. T., Urrutia, A., Cardinaud, S., Buzón, M. J., Izquierdo‐Useros, N., Prado, J. G., Puertas, M. C., Erkizia, I., Coulon, P.-G. A., Cedeño, S., et al. (2012) · Retrovirology · doi:10.1186/1742-4690-9-s2-p2 · Cited by 4
“HIV-1 virions containing the b-lactamase (BlaM)-Vpr chimera were produced, as previously described (27).”
InfluentialBarat, C., Pépin, J., & Tremblay, M. J. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.03.012 · Cited by 4
“First, we gained evidence that the drug does not modulate the amount of viral particles captured by iDCs, or the fusion efficiency of those particles, as assessed by a fusion assay based on virions carrying β-lactamase–Vpr chimeric proteins (data not shown).(18) By contrast, when melarsoprol was added 24 h after virus…”
ResultMembrane Fusion Assays for Studying Entry Hepatitis C Virus into Cells
Denolly, S., Cosset, F., & Freitas, N. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8976-8_15 · Cited by 4
Human Immunodeficiency Viruses: Propagation, Quantification, and Storage
Richards, K. H., & Clapham, P. R. (2006) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc15j01s02 · Cited by 4
“Another reporter virus system that has been adapted to evaluate the first events in HIV entry utilizes a β-lactamase-vpr fusion protein (Cavrois et al., 2002).”
BackgroundHIV-1 signalling remodels nuclear pores to licence infection
Mesner, D., Whelan, M. V. X., Shivkumar, M., Reuschl, A., Chiozzi, R. Z., Thalassinos, K., de Bruin, R. A. M., & Jolly, C. L. (2026) · Nature · doi:10.1038/s41586-026-10453-3 · Cited by 4
Nair, R., Salinas-Illarena, A., Sponheimer, M., Wullkopf, I., Schreiber, Y., Côrte‐Real, J. V., Ben, A. D. P., Marterer, H., Thomas, D., Geißlinger, G., et al. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01425-w · Cited by 3
“In order to determine the VSV-G-dependent fusion efficiency, a virion fusion assay was performed [23].”
MethodThe Antisense Protein ASP of HIV-1 Enhances Viral Entry in CD4+ T Cells
Houmey, M. A., Caico, I., Rivault, A., Espert, L., Mesnard, J.-M., Romerio, F., & Chazal, N. (2025) · Viruses · doi:10.3390/v17101332 · Cited by 3
“Blam-Vpr Assay was performed as previously described [18].”
Prestimulation of CD2 confers resistance to HIV-1 latent infection in blood resting CD4 T cells
He, S., Guo, J., Fu, Y., Spear, M., Qin, C., Fu, S., Cui, Z., Jin, W., Xu, X., Chen, W., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103305 · Cited by 3
“The BlaM-Vpr-based viral fusion assay was performed as previously described (Cavrois et al., 2002).”
MethodIrreversible Loss of HIV-1 Proviral Competence in Myeloid Cells upon Suppression of NF-κB Activity
Peters, R. J., & Stevenson, M. (2022) · Journal of Virology · doi:10.1128/jvi.00484-22 · Cited by 3
Exposure to Secreted Bacterial Factors Promotes HIV-1 Replication in CD4 + T Cells
Znaidia, M., de Souza-Angelo, Y., Létoffé, S., Staropoli, I., Grzelak, L., Ghigo, J., Schwartz, O., & Casartelli, N. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04313-22 · Cited by 3
Kramer, S., Buontempo, P. J., Agrawal, S., & Ralston, R. (2011) · SLAS DISCOVERY · doi:10.1177/1087057111403480 · Cited by 3
Mechanisms of Ebola Virus Entry
Shoemaker, C. J. (2012) · doi:10.18130/v3756g · Cited by 3
Assessing the fitness of Epstein-Barr virus following its reactivation
Chen, Y. A., Mocanu, B., Akidil, E., Pich, D., Mautner, J., Sugden, B., & Hammerschmidt, W. (2025) · Journal of Virology · doi:10.1128/jvi.00626-25 · Cited by 2
Exploring the secrets of virus entry: the first respiratory syncytial virus carrying beta lactamase
De-Ávila-Arias, M., Camacho, J. L. V., Cadena-Cruz, C., Hurtado-Gómez, L., Costello, H. M., Rodríguez, A., Burgos-Flórez, F. J., Bettin, A., Kararoudi, M. N., Muñoz-Acevedo, A., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1339569 · Cited by 2
Mofed, D., Mandarino, A., Wu, X., Lang, Y., Gowripalan, A., Kalpana, G. V., & Prasad, V. R. (2024) · Viruses · doi:10.3390/v16121859 · Cited by 2
“Interestingly, a vast majority of these vectors have been based on HIV-1 subtype B. Reporter viruses carrying the luciferase gene are used to monitor virus-cell membrane fusion [16], nuclear entry, loss of capsid integrity, and uncoating [17].”
5.15 Mechanisms of Enveloped Virus Entry by Membrane Fusion
Melikyan, G. B., Smith, E. C., & Dutch, R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374920-8.00524-5 · Cited by 3
Human plasma amino acid balance favours HIV-1 replication in primary CD4 T lymphocytes
Chauveau, L., Fortuin, A., Lecante, A., Tellier, A., Lager-Lachaud, N., Honne, S., Boulay, A., Blanchet, F. P., Kim, B., Bellvert, F., et al. (2026) · EMBO Reports · doi:10.1101/2024.12.10.627699 · Cited by 1
Janevska, M., Witkowski, W., Vermeíre, J., Borowicz, M., Naessens, E., Vanderstraeten, H., Nauwynck, H., Favoreel, H. W., & Verhasselt, B. (2025) · Journal of Virology · doi:10.1128/jvi.02066-24 · Cited by 1
IL-4 downregulates gap junction protein connexin 26 to promote HIV-1 infection in macrophages
Wang, S., Zhang, J., Liu, Y., Zhao, L., Zhang, Y., Liang, G., & Shang, H. (2025) · mBio · doi:10.1128/mbio.01626-25 · Cited by 1
“To elucidate the underlying molecular mechanism of GJB2 inhibition of HIV-1 infection, we analyzed the entry efficiency of HIV-1 particles into target cells in the presence of GJB2 using a β-lactamase (BlaM)-fused Vpr entry assay (32).”
Markosyan, R. M., Marin, M., & Melikyan, G. B. (2025) · mBio · doi:10.1128/mbio.02793-25 · Cited by 1
“…cells and cells ectopically expressing SER2-GFP or SER5-GFP (to assess the efficiency of SERINC transfection) were inoculated with pseudoviruses bearing SER5-sensitive (HXB2) Env or SER5-resistant (JRFL) Env, and the resulting fusion was measured using a beta-lactamase (BlaM) assay (32, 33, 55).”
Larios, R., Hossain, M. B., Brown, R., Jeyachandran, A. V., Abu, A. E. I., Zaiss, A. K., Ramirez, C. M., Kamata, M., Cole, S., Wu, T.-T., et al. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1013946 · Cited by 1
“D) After confirmation of CD4 and CXCR4 dependency of HIV-1 virion-incorporated Scarlet (to quantitate virus binding), virion-incorporated β -lactamase (to quantitate fusion) [45], and a EGFP reporter gene sequence (to quantitate virus infection/transduction).”
InfluentialYi, F., Guo, J., Vo, T. T., Hetrick, B., Haikerwal, A., Zhou, Z., Sealey, L., He, S., Han, Y., Chilin, L. D., et al. (2026) · Science Advances · doi:10.1126/sciadv.aeb5548 · Cited by 1
“We further quantified the effects of N9 on HIV entry using the Vpr-based lactamase entry assay ( 36 ) and found an enhancement of viral entry in N9-treated CD4 T cells (Fig.”
Rapid titration of retroviral vectors using a β-lactamase protein fragment complementation assay
Ou, W., Marino, M. P., Lu, C.-L., & Reiser, J. (2012) · Gene Therapy · doi:10.1038/gt.2011.212 · Cited by 1
Tso, F. Y., Abrahamyan, L. G., Hu, S.-L., Ruprecht, R. M., & Wood, C. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066973 · Cited by 1
Strategies for Virus–Enzyme Coupling
Cardinale, D., Carette, N., & Michon, T. (2015) · doi:10.1201/b18970-6 · Cited by 1
Probing conformational dynamics in biopolymers by contact-induced fluorescence quenching
Doose, S., Neuweiler, H., & Sauer, M. (2007) · Handai Nanophotonics · doi:10.1016/s1574-0641(07)80011-8 · Cited by 1
Souriant, S., Balboa, L., Pingris, K., Kviatcovsky, D., Cougoule, C., Lastrucci, C., Bah, A., Gasser, R., Poincloux, R., Raynaud‐Messina, B., et al. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3244797 · Cited by 1
Schiff, A. E. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 1
Chen, Y. A., Mocanu, B., Akidil, E., Pich, D., Mautner, J., & Hammerschmidt, W. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.26.439973 · Cited by 2
“The β-lactamase (BlaM) assay has been developed in the HIV field to detect fusion of HIV particles with T cells (Cavrois et al., 2002; Jones and Padilla-Parra, 2016).”
MethodTso, F. Y. (2013) · Lincoln (University of Nebraska)
Harmon, B. (2009) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7p55kht
“It compares favorably with other assays of virus, such as one that depends upon transfer of a virus core containing a Vpr-β-lactamase fusion protein into a target cell, which requires a longer incubation time and FACS analyses (118, 119).”
MethodMechanisms of antibody-mediated protection for a protein-based smallpox vaccine
Cohen, M. E. (2011) · ScholarlyCommons (University of Pennsylvania)
Functional aspects of new helper factors for HIV replication
Godinho‐Santos, A. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Brandano, L. A. (2011) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/5zmj-9x81
Guedj, C. (2014) · theses.fr (ABES) · doi:10.70675/4087ecbaza444z426az815ez42182365c468 · Cited by 1
Waltke, M. (2012) · Lincoln (University of Nebraska)
Eissmann, K., Mueller, S., Sticht, H., Jung, S., Zou, P., Jiang, S., Gross, A., Eichler, J., Fleckenstein, B., & Reil, H. (2014) · PLoS ONE · doi:10.1371/annotation/b46459e1-73ff-4b75-8f24-264cbcf4a5a9
Harada, T., Tatsumi, M., Takahashi, H., Sata, T., Kurata, T., & Kojima, A. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.02.002
Cellular Pathways for Productive HIV-1 Entry and Molecular Mechanisms of its Inhibition.
Song, H. (2015) · Deep Blue (University of Michigan)
Characterization of the infection mechanism during cell-to-cell transmission of HIV-1
Permanyer, M. (2013) · TDX (Tesis Doctorals en Xarxa)
Characteristics of a Block to Entry via an HIV-2 Envelope, MCRPreprint
Gray, E. R. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/177808
Tardif, M. R. (2005) · Corpus Université Laval (Université Laval)
Claireaux, M. A. F. (2017) · theses.fr (ABES) · doi:10.70675/22792687za5c7z448ez84d9z0285f732e52b
Baldauf, H. (2018) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.24163 · Cited by 1
New insights into HIV-1 restriction - functional studies on 90K orthologues and endogenous SERINC5
Kohn, V. P. M. P. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/9n63-rh70
Seidman, D. L., Cavrois, M., Hilton, J. F., Roan, N. R., Averbach, S., Takeda, M., Chang, E., Raman, N., Greenblatt, R. M., Shacklett, B. L., et al. (2020) · Contraception · doi:10.1016/j.contraception.2020.09.003
“In this crosssectional study, we used a novel ex vivo HIV-1 fusion assay [9] to determine whether there are differences in HIV-1 susceptibility of target cells isolated from cervix and endometrium from women using DMPA or during pregnancy compared to non-pregnant women not using hormonal or intrauterine contraception.”
MethodSelf-citationAssessing Immunological and Microbiome Determinants of HIV Susceptibility in the Male Genital Tract
Galiwango, R. M. (2020) · TSpace (University of Toronto)
Tauzin, A. (2020) · theses.fr (ABES) · doi:10.70675/47aaa60dz2c00z416bz83c6z64326da6c3dc · Cited by 1
Yegorov, S. (2018) · TSpace (University of Toronto) · Cited by 1
Strategies for Virus–Enzyme Coupling
Cardinale, D., Carette, N., & Michon, T. (2015) · Pan Stanford eBooks · doi:10.1201/b18970-3
Envolvimento de miosinas na infecção por HIV-1 de células mieloides
Kogachi, L. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2022.tde-24082022-164251 · Cited by 1
Kubheka, M. X. (2024) · ResearchSpace (University of KwaZulu-Natal) · doi:10.29086/10413/22998
He, S., Haikerwal, A., Tiwari, S., Dabbagh, D., Alam, M. Z., Yoon, J. L., Hetrick, B., Han, Y., Shan, L., Lockhart, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.15.643450
Humanized rabbit entry receptor complex supports HIV-1 entry into rabbit cellsPreprint
Côrte‐Real, J. V., de Sousa-Pereira, P., Lotke, R., Schelle, L., Fröhlich, A. L., Esteves, P. J., Abrantes, J., Kalinina, O. V., Sauter, D., & Hanna-Mari (2025) · Research Square · doi:10.21203/rs.3.rs-7973543/v1
Rôle de la protéine antisens (ASP) dans le cycle de réplication du VIH-1
Houmey, M. A. (2024) · HAL
Screening Dynamic Phenotypes for Synthetic Biology
Perez, J. F. (2023) · Spectrum Research Repository (Concordia University)
Investigating transcriptomic markers of SARS-CoV-2 response
Darmalinggam, S. (2025) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.35720
Identifying biophysical determinants of virus-cell fusion through live-cell imaging
Coomer, C. A. (2021) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-aenoovaj2
Selective reactivation of latent HIV using CyclinT1-Tat-containing virus-like particles
Lavin, T. K., Tabler, C. O., Sweet, T. J., Alhusaini, N., & Tilton, J. C. (2026) · Virology · doi:10.1016/j.virol.2026.110788
宿主抑制因子SERINC5の412番目の芳香族アミノ酸はHIV-1およびレトロウイルスに対する阻害活性を担う
Tan, T. S. (2022) · Institutional Repositories DataBase (IRDB)
Herit, F., Lê-Bury, G., Provôt, Q., To-Puzenat, D., Haagen, J., Matozo de Souza, T., Dumas, A., Morel, M., Margottin-Goguet, F., Sagné, C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.06.709337
“Enzymatic cleavage of CCF2/AM (Cavrois et al., 2002) was assessed by flow cytometry (LSR II, BD).”
Arp2/3 complex-dependent actin remodeling is required for efficient RSV uncoating in A549 cells
Xie, E., Schubert, M., Fricke, J. M., Seligmann, B., Schaks, M., Müsken, M., Steffen, A., Stradal, T. E. B., Haid, S., Rottner, K., et al. (2026) · Journal of Virology · doi:10.1128/jvi.01117-26
“This approach was adapted from β-lactamase (BlaM)-based entry assays originally developed for human immunodeficiency virus type 1 (HIV-1) (40) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (41).”
Implication des protéines EHD4 et EHD1 dans le cycle de réplication du VIH-1
Pacini, G. (2016) · theses.fr (ABES) · doi:10.70675/c3269659z55a7z4e63z9e03z044a2aab8cee
Recherche de signaux d'empaquetage spécifiques du génome des virus influenza A
Gerber, M. (2016) · theses.fr (ABES) · doi:10.70675/8ee03baaz1a11z4c9az8cedzc614891493cc · Cited by 2
Identification et caractérisation d’une nouvelle famille de facteur de restriction - les IFITMs
Tartour, K. (2014) · theses.fr (ABES) · doi:10.70675/ec615830zd77fz4c07zba10z84319d26ea83
Shigella pathogenicity beyond cell invasion : the new kiss-and-run paradigm
Pinaud, L. (2016) · theses.fr (ABES) · doi:10.70675/6e705b2bz2a6fz450bzb795z2c5784082492
HCV assembly : from clustering of viral assembly factors to envelopment and lipidation of particles
Denolly, S. (2018) · theses.fr (ABES) · doi:10.70675/57cf5cd6z310bz4819zad26zbd5b7dd1deae
Bonaventure, B. (2020) · theses.fr (ABES) · doi:10.70675/768c3190z3177z4b25z88b9z9a029e425462 · Cited by 1
Armani-Tourret, M. (2021) · theses.fr (ABES) · doi:10.70675/5ed5ae57z0e50z4110zba11zb0f4871eadeb
Cantaloube-Ferrieu, V. (2023) · theses.fr (ABES) · doi:10.70675/e7422723z7cb9z4feczba3bz407046e4c995
A tissue-intrinsic mechanism sensitizes HIV-1 particles for TLR-triggered innate immune responses
Ahmed, S. S., Zimmermann, L., Imle, A., Wuebben, K., Tibroni, N., Rauch‐Wirth, L., Münch, J., Chlanda, P., Graw, F., & Fackler, O. (2026) · Nature Communications · doi:10.1038/s41467-026-72586-3
Thrush, J. W., Jones, L. M., Carlón-Andrés, I., Carroll, M. W., Padilla‐Parra, S., & Owens, R. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.22.727168
“NiVM was recombinantly fused with a beta-lactamase enzyme, which acted as the reporter protein for VLP-cell fusion 32 .”
Generation and evaluation of an EcoHIV mouse model to study HIV-1 integration and expression
Wei, W., Zhou, Y., (88810), Y. M., Yang, Z., Xia, X., Ma, Y., Gao, Y., Wang, C., Liu, J., Liu, Y., et al. (2026) · Virology · doi:10.1016/j.virol.2026.110991
Development of a virus particle fusion assay to study and target virus entry
Terzopoulos, N., Tiplady, O., Pan, Q., & Liang, C. (2026) · Virology · doi:10.1016/j.virol.2026.111025
BRCA1-RAD51 homologous DNA repair pathway promotes HIV-1 reverse transcription
Lapaillerie, D., Tumiotto, C., Scoca, V., Figueiredo, S., Maisch, M., Bertinetti, C., Mougel, M., Fleury, F., Lesbats, P., Delelis, O., et al. (2026) · Science Advances · doi:10.1126/sciadv.aea2430 · Cited by 1
“Measurement of virus cell fusion efficiency was performed using chimeric viruses containing a Vpr protein fused with the β - lactamase (Vpr-BLaM) ( 59 ).”
Sequential HIV-1 fusion protein gates control the initiation of host cell entryPreprint
Do, H., Lella, M., Fulmali, D., Rajpara, N., Unarta, I. C., Johnson, A., Janowska, K., Laukaitis, H., Saunders, C., Edwards, R. J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.06.743292
Zikhali, N. V. (2025) · ResearchSpace (University of KwaZulu-Natal)
Altamura, L. A. (2008) · Scholarly Commons (University of Pennsylvania)
Studies on Cellular Host Factors Involved in the HIV-1 Life Cycle: A Dissertation
Serquiña, A. (2012) · eScholarship@UMassChan · doi:10.13028/2gzz-cy82
“Greene and colleagues (Cavrois et al. 2002)and L.”
Metadata
- Authors
- Cavrois, M., de Noronha, C., & Greene, W. C.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Greene, Warner C.
- Venue
- Nature Biotechnology
- Published
- 2002-09-30
- Volume
- 20
- Issue
- 11
- Pages
- 1151-1154
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2029379203
- Cited by
- 475
- References
- 16
- Citations by year
- 2026: 13 · 2025: 11 · 2024: 12 · 2023: 9 · 2022: 19 · 2021: 24 · 2020: 22 · 2019: 25 · 2018: 20 · 2017: 31 · 2016: 16 · 2015: 27 · 2014: 28 · 2013: 22 · 2012: 31
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P01 HD40543, P01HD040543)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- HIV-1, viral entry, fluorescent substrate, HIV-1 envelope
- MeSH terms
- Cell Fusion, Humans, Immunoenzyme Techniques, Membrane Fusion, Sensitivity and Specificity, T-Lymphocytes, Tumor Cells, Cultured, Viral Fusion Proteins, Virion, Reproducibility of Results, HIV-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.